Back

Prognostic impact of maximum vasodilation therapy in heart failure

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Heart failure in the real world Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Carlos Aurelio Santos Aragao

Charitable Foundation Hospital of Surgery, Aracaju (Brazil)

7 More presentations in this session

Presentation thumbnail
Real-world treatment patterns in newly diagnosed heart failure patients stratified by ejection fraction subtype in Japan
Doctor R. Knapp (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
EVOLUTION-HF DEallEF: a non-interventional study program of patients with heart failure and initiated on dapagliflozin: results of 1st interim analysis
Professor M. Paul (Muenster, DE)
Abstract Slides Video
Presentation thumbnail
Association between calcium channel blockers prescription and outcome according to left ventricular ejection fraction: data from a real-world heart failure population
Doctor M. Gori (Bergamo, IT)
Abstract Slides Video
Presentation thumbnail
Outpatient diuretic use in patients with baroreflex activation therapy
Doctor L. Straw (Columbia, US)
Abstract Slides Video
Presentation thumbnail
Active vs passive best-practice alerts to improve guideline-directed lipid-lowering therapy intensification in patients with recent myocardial infarction and elevated LDL-C
Doctor D. Karalis (Philadelphia, US)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure in the real world

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
ESC Heart Failure
thumbnail
Congress Presentation
Vasodilators in the emergency department: friend or foe?
thumbnail
Congress Session
Treatment of HFrEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources